385 related articles for article (PubMed ID: 29052435)
21. Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study.
Karayiannides S; Norhammar A; Landstedt-Hallin L; Friberg L; Lundman P
Eur J Prev Cardiol; 2022 Oct; 29(13):1759-1769. PubMed ID: 35580601
[TBL] [Abstract][Full Text] [Related]
22. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.
Piccini JP; Hammill BG; Sinner MF; Hernandez AF; Walkey AJ; Benjamin EJ; Curtis LH; Heckbert SR
Eur Heart J; 2014 Jan; 35(4):250-6. PubMed ID: 24282186
[TBL] [Abstract][Full Text] [Related]
23. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
[TBL] [Abstract][Full Text] [Related]
24. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.
Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M
Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346
[TBL] [Abstract][Full Text] [Related]
27. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
28. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
[TBL] [Abstract][Full Text] [Related]
29. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
[TBL] [Abstract][Full Text] [Related]
30. Reduced risk of death with warfarin - results of an observational nationwide study of 20 442 patients with atrial fibrillation and ischaemic stroke.
Åsberg S; Eriksson M; Henriksson KM; Terént A
Int J Stroke; 2013 Dec; 8(8):689-95. PubMed ID: 22928583
[TBL] [Abstract][Full Text] [Related]
31. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
32. Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
Overvad TF; Skjøth F; Lip GY; Lane DA; Albertsen IE; Rasmussen LH; Larsen TB
Stroke; 2015 Aug; 46(8):2168-74. PubMed ID: 26152296
[TBL] [Abstract][Full Text] [Related]
33. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
[TBL] [Abstract][Full Text] [Related]
34. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
[TBL] [Abstract][Full Text] [Related]
36. Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?
Ancedy Y; Berthelot E; Lang S; Ederhy S; Boyer-Chatenet L; Di Angelantonio E; Soulat-Dufour L; Etienney A; Adavane-Scheublé S; Boccara F; Cohen A
Arch Cardiovasc Dis; 2018 May; 111(5):357-369. PubMed ID: 29685722
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population.
Eranti A; Aro AL; Kerola T; Anttonen O; Rissanen HA; Tikkanen JT; Junttila MJ; Kenttä TV; Knekt P; Huikuri HV
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1116-21. PubMed ID: 25381332
[TBL] [Abstract][Full Text] [Related]
38. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
40. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
Jil M; Rajnikant M; Richard D; Iskandar I
Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
